Global DPT Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global DPT Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humansdiphtheria, pertussis (whooping cough), and tetanus.
DPT Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global DPT Vaccines market is projected to reach US$ 6619.4 million in 2034, increasing from US$ 5187.9 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2034. Demand from 12 Months Below and 12 Months Above are the major drivers for the industry.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global DPT Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Age and Regions Listed in the Report
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the DPT Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of DPT Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the DPT Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of DPT Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Age, Volume and Revenue analysis of Each Age in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, DPT Vaccines introduction, etc. DPT Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of DPT Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
DPT Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global DPT Vaccines market is projected to reach US$ 6619.4 million in 2034, increasing from US$ 5187.9 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2034. Demand from 12 Months Below and 12 Months Above are the major drivers for the industry.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global DPT Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Age and Regions Listed in the Report
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the DPT Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of DPT Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the DPT Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of DPT Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Age, Volume and Revenue analysis of Each Age in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, DPT Vaccines introduction, etc. DPT Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of DPT Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.